Literature DB >> 31778687

Down-regulation of Tet2 is associated with Foxp3 TSDR hypermethylation in regulatory T cell of allergic rhinitis.

Lu Tan1, Ting Qiu1, Rong Xiang1, Cheng Cao1, Yuqin Deng1, Zezhang Tao1, Yu Xu2.   

Abstract

AIMS: Ten-eleven-translocation (Tet) proteins are 5-methylcytosine oxidases and have profound impact on DNA methylation and genes expression. This study aimed to investigate the role of Tet2 and its association with Foxp3 DNA methylation in regulatory T (Treg) cell of allergic rhinitis (AR).
MATERIALS AND METHODS: CD4+CD25+Treg cells were sorted from peripheral blood lymphocytes drawn from AR patients and spleen lymphocytes drawn from OVA-exposed mice by flow cytometry. Tet2 and Foxp3 expressions were studied in sorted Treg cells. DNA methylation of CpG sites in Foxp3 in Treg cells was analyzed by pyrosequencing. TET2 protein binding to Foxp3 DNA in Treg cells was detected by chromatin immunoprecipitation followed by quantitative PCR (ChIP-qPCR). KEY
FINDINGS: Treg cells drawn from AR patients and OVA-exposed mice showed reduction in cells counts, expression of Foxp3 mRNA and protein and down-regulation of Tet2, compared with the controls. Hypermethylation of Foxp3 TSDR and decline of TET2 binding to Foxp3 TSDR, but not promoter, were noted in Treg cells of OVA-exposed mice. Significant negative correlations between Tet2 expression and Foxp3 TSDR methylation, Foxp3 TSDR methylation and Foxp3 expression, and positive correlation between Foxp3 expression and Treg cells percentage were demonstrated by correlation analysis. SIGNIFICANCE: This study demonstrated that down-regulation of Tet2 was associated with higher methylation level of Foxp3 TSDR, reduction in Foxp3 expression and Treg cells percentage in AR, suggesting that Tet2 probably modulated the function of Treg cells in AR through Foxp3 methylation.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Allergic rhinitis; DNA methylation; Foxp3; Regulatory T cell; Tet2

Mesh:

Substances:

Year:  2019        PMID: 31778687     DOI: 10.1016/j.lfs.2019.117101

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  6 in total

1.  IL-4/IL-13 Axis in Allergic Rhinitis: Elevated Serum Cytokines Levels and Inverse Association With Tight Junction Molecules Expression.

Authors:  Siti Muhamad Nur Husna; Norasnieda Md Shukri; Sharifah Emilia Tuan Sharif; Hern Tze Tina Tan; Noor Suryani Mohd Ashari; Kah Keng Wong
Journal:  Front Mol Biosci       Date:  2022-03-17

2.  TET2 Regulates 5-Hydroxymethylcytosine Signature and CD4+ T-Cell Balance in Allergic Rhinitis.

Authors:  Lu Tan; Lisheng Fu; Li Zheng; Wenjun Fan; Hanyu Tan; Zezhang Tao; Yu Xu
Journal:  Allergy Asthma Immunol Res       Date:  2022-03       Impact factor: 5.764

3.  Mesenchymal stromal cells-derived small extracellular vesicles modulate DC function to suppress Th2 responses via IL-10 in patients with allergic rhinitis.

Authors:  Ya-Qi Peng; Zi-Cong Wu; Zhi-Bin Xu; Shu-Bin Fang; De-Hua Chen; Hong-Yu Zhang; Xiao-Qing Liu; Bi-Xin He; Dong Chen; Cezmi A Akdis; Qing-Ling Fu
Journal:  Eur J Immunol       Date:  2022-04-24       Impact factor: 6.688

Review 4.  Contribution of Regulatory T Cell Methylation Modifications to the Pathogenesis of Allergic Airway Diseases.

Authors:  Jiani Li; Jichao Sha; Liwei Sun; Dongdong Zhu; Cuida Meng
Journal:  J Immunol Res       Date:  2021-06-19       Impact factor: 4.818

5.  miR-31 attenuates murine allergic rhinitis by suppressing interleukin-13-induced nasal epithelial inflammatory responses.

Authors:  Fangwei Zhou; Peiqiang Liu; Hao Lv; Ziang Gao; Wenchuan Chang; Yu Xu
Journal:  Mol Med Rep       Date:  2020-11-12       Impact factor: 2.952

6.  Menstrual blood-derived mesenchymal stem cells attenuate inflammation and improve the mortality of acute liver failure combining with A2AR agonist in mice.

Authors:  Dazhi Chen; Ruichao Zeng; Guigen Teng; Chao Cai; Tongtong Pan; Hanxiao Tu; Hongwei Lin; Qingjing Du; Huahong Wang; Yongping Chen
Journal:  J Gastroenterol Hepatol       Date:  2021-04-05       Impact factor: 4.029

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.